The Bank may also selectively make equity investments through financial intermediaries, such as equity funds, choosing those managed by professional managers with relevant track records and remuneration arrangements in line with market practices.
In both direct and indirect equity investments, the Bank seeks credible exit strategies.
Financing Portfolio
As of December 31, 2023, the Bank has approved 252 financings (including 199 loans, 33 investments in funds, four equity financings, 13 investments in fixed-income securities and three guarantees) with a total amount of US$50,467.9 million. This amount includes financings approved as of December 31, 2023 under the COVID-19 Crisis Recovery Facility (the “CRF”). See “–AIIB Response to the COVID-19 Pandemic and its Effects.” Of these financings, 216 were approved by the Board of Directors with a total approved amount of US$45,615.6 million, and 36 were approved by the President, pursuant to his delegated authority to approve certain financings, with a total approved amount of US$4,852.3 million. Of the approved financings, the Bank has terminated or cancelled eight financings. Of the eight terminated or cancelled financings, seven were loans with a total amount of US$1,132.0 million, and one was a fixed-income investment with a total amount of US$95.0 million.
As of December 31, 2023, the aggregate amount of approved loans, excluding terminated or cancelled loans, totaled US$42,690.9 million, of which US$11,959.4 million were committed amounts and US$23,371.0 million were disbursed amounts. Committed amounts are amounts the Bank has approved and committed to provide pursuant to legally binding documentation, but has not yet disbursed. For sovereign-backed loans, these amounts are further limited to financings for which all conditions precedent required for disbursement have been satisfied. Disbursed amounts as of December 31, 2023 are on a cash basis. Disbursed amounts included in the tables below represent the gross carrying amount of the loans (i.e., including the transaction costs and fees that are capitalized through the effective interest method). Of all approved loans as of December 31, 2023, 149 were sovereign-backed and 50 were non-sovereign-backed loans; 113 were co-financings and 86 were stand-alone financings.
As of December 31, 2023, approved investments in funds totaled US$2,945.0 million, of which the Bank has disbursed US$900.7 million.
As of December 31, 2023, approved equity financings totaled US$227.0 million, of which the Bank has disbursed US$138.6 million.
As of December 31, 2023, approved investments in fixed-income securities totaled US$2,073.0 million, of which the Bank has disbursed US$1,410.7 million.
As of December 31, 2023, the approved guarantees totaled US$1,400.0 million, of which the Bank has made no disbursements.
As of December 31, 2023, approved financings (including approved financings under the CRF) span a broad range of sectors, including energy, digital infrastructure and technology, transport, urban, water, education infrastructure, economic resilience/policy-based financing (CRF), public health (CRF), finance/liquidity (CRF), rural infrastructure and agricultural development, health infrastructure and other and, excluding multi-country financings (discussed below), would fund projects in the following members: Argentina; Azerbaijan; Bangladesh; Brazil; Cambodia; China; Cook Islands; Côte d’Ivoire; Ecuador; Egypt; Fiji; Georgia; Hong Kong, China; Hungary; India; Indonesia; Jordan; Kazakhstan; Kyrgyz Republic; Lao PDR; Maldives; Mongolia; Myanmar; Nepal; Oman; Pakistan; Philippines; Romania; Russia (as described under “–Recent Developments–AIIB Response to the Conflict in Ukraine,” all activities relating to Russia and Belarus are currently on hold and under review); Rwanda; Singapore; Sri Lanka; Tajikistan; Türkiye; Uzbekistan; and Viet Nam. As of December 31, 2023, of the approved financings, 26 (23 investments in funds, two investments in fixed-income securities and one guarantee) were classified as multi-country financings.
AIIB Response to the COVID-19 Pandemic and Its Effects
The COVID-19 pandemic has had and continues to have an adverse impact on the global economy and on the individual economies of AIIB members. AIIB members continue their efforts to contain the effects of COVID-19 pandemic and to mitigate the risks of long-lasting, structural harm to their economies. Developing economies, especially those with weak health care infrastructure, vulnerable macroeconomic or financial sector fundamentals or a high dependence on tourism, commodities exports or remittances, required support from the international financial community to respond to and contain the COVID-19 pandemic.
29